ICD-10 Coding for Chemotherapy-Induced Diarrhea(K52.1, K52.1B, K52.1T)
Learn about the ICD-10 coding for chemotherapy-induced diarrhea, including documentation requirements and coding pitfalls.
Complete code families applicable to Chemotherapy-Induced Diarrhea
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| K52.1 | Toxic gastroenteritis and colitis | Use when colitis or gastroenteritis is confirmed as drug-induced by chemotherapy. |
|
| T45.1X5A | Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter | Use when documenting the adverse effect of chemotherapy drugs. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutChemotherapy-Induced Diarrhea
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Chemotherapy-Induced Diarrhea.
Vague documentation of diarrhea without specifying colitis.
Impact
Clinical: May lead to under-treatment or mismanagement., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims or incorrect billing.
Mitigation
Ensure documentation specifies colitis if present., Use diagnostic tests to confirm colitis.
Using K52.1 for 'chemotherapy-induced diarrhea' without colitis confirmation.
Impact
Reimbursement: Incorrect coding may lead to denied claims or incorrect DRG assignment., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate clinical data affecting patient records.
Mitigation
Query provider to confirm whether colitis/gastroenteritis is present.
Incorrect Code Sequencing
Impact
Improper sequencing of primary and secondary codes.
Mitigation
Educate staff on correct sequencing rules and provide coding guidelines.